Dvorah Richman
Dvorah Richman is a life sciences regulatory attorney with extensive industry and law firm experience focused on government laws, regulations and policies regarding a wide variety of products and topics.
She served as in-house and outside regulatory counsel to FDA-regulated companies for over 35 years. Her most recent industry position was VP, Chief Regulatory Counsel to Siemens Healthineers. Prior positions included FDA and Regulatory Counsel to Life Technologies, Senior Regulatory Counsel to Olympus Corporation of the Americas, and Partner with the law firm of King & Spalding. Throughout this time, she worked closely with business leaders, corporate lawyers, legislative staff, and clinical and regulatory affairs and compliance personnel to resolve complicated regulatory and business issues.
Dvorah has conducted many corporate seminars and spoken at various industry conferences about diverse regulatory, compliance and legal topics. She has written articles for The Food, Drug and Cosmetic Law Journal, Medical Device & Diagnostic Industry, Spine Letter, China’s Health News, RealClearPolicy, Townhall and other publications.
Prior to becoming a lawyer, Dvorah was Director of Speech Pathology services for Denver Head Start and a Budget and Legislative Analyst for the Colorado Senate Joint Budget Committee. She recently served as an Adjunct Professor at the University of Maryland, Baltimore campus, where she taught a graduate course about global regulatory concepts.
Dvorah earned her B.S. degree in Speech Pathology from Arizona State University, her M.A. in Communications Disorders from the University of Denver, and her J.D. from the Catholic University of America School of Law.
Advertisment
Latest News
FDA Wants to Fix Outdated Recall System
The U.S. Food and Drug Administration (FDA) recently announced a public “listening session” about “modernizing” its product recall system.
The FDA has the authority to recall drugs, medical devices, and foods for human...
New Science Policy: No Apologies for COVID Mistakes
The White House Office of Science and Technology Policy (OSTP) published a Scientific Integrity Policy (SIP) for federal agencies, on June 22.
The purpose of the SIP is “to provide instruction and guidance...
FDA Refuses to Remove Alleged Misinformation from COVID Shot Labeling
A group of drug safety advisors and academics is speaking out against a decision by the Food and Drug Administration (FDA) to amend the labeling for the Pfizer and Moderna mRNA inoculations...
Dvorah Richman
Dvorah Richman is a life sciences regulatory attorney with extensive industry and law firm experience focused on government laws, regulations and policies regarding a wide variety of products and topics.
She served as in-house and outside regulatory counsel to FDA-regulated companies for over 35 years. Her most recent industry position was VP, Chief Regulatory Counsel to Siemens Healthineers. Prior positions included FDA and Regulatory Counsel to Life Technologies, Senior Regulatory Counsel to Olympus Corporation of the Americas, and Partner with the law firm of King & Spalding. Throughout this time, she worked closely with business leaders, corporate lawyers, legislative staff, and clinical and regulatory affairs and compliance personnel to resolve complicated regulatory and business issues.
Dvorah has conducted many corporate seminars and spoken at various industry conferences about diverse regulatory, compliance and legal topics. She has written articles for The Food, Drug and Cosmetic Law Journal, Medical Device & Diagnostic Industry, Spine Letter, China’s Health News, RealClearPolicy, Townhall and other publications.
Prior to becoming a lawyer, Dvorah was Director of Speech Pathology services for Denver Head Start and a Budget and Legislative Analyst for the Colorado Senate Joint Budget Committee. She recently served as an Adjunct Professor at the University of Maryland, Baltimore campus, where she taught a graduate course about global regulatory concepts.
Dvorah earned her B.S. degree in Speech Pathology from Arizona State University, her M.A. in Communications Disorders from the University of Denver, and her J.D. from the Catholic University of America School of Law.